Merck
For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.
Kenneth C. Frazier

Kenneth C. Frazier

Executive Chairman of the Board, Merck

Find out more

We believe it is vital to state clearly to the world the set of our beliefs about Inclusive Capitalism. As such, we start with our Statement of Guiding Principles for Inclusive Capitalism. Knowing that words alone are not enough, each of us is making a series of commitments about how we will operate our institutions so that they help achieve Inclusive Capitalism. These commitments are forward-looking statements based on current goals, expectations and assumptions, which are not guarantees of future performance. For more information, please refer to our Terms of Use

Filter by commitments

View all
Planet icon Planet
Principles of Governance icon Principles of Governance
People icon People
Prosperity icon Prosperity

Summary

Use environmental design criteria in the development of our manufacturing processes and packaging. By 2020, at least 90% of new human health active pharmaceutical ingredient processes will meet internal sustainability targets at launch.

Objectives

Use green and sustainable design principles and other environmental design criteria in the development of our manufacturing processes and packaging right from the start

Metrics & Targets

  • By 2020, at least 90% of new human health active pharmaceutical ingredient processes will meet internal sustainability targets at launch.
  • 100% of the packaging for new human health products reviewed for environmental impact and improvement.

SDG Focus Area(s):

Summary

Reduce GHG emissions and other associated air pollutants. By 2025, become carbon neutral across operations (Scopes 1&2 GHG emissions).

Objectives

Reduce GHG emissions and other associated air pollutants by driving energy efficiency improvements and purchasing more electricity from renewable sources of energy, such as wind and solar

Metrics & Targets

  • By 2025, become carbon neutral across company operations (scopes 1&2 GHG emissions)
  • By 2030, reduce company’s value chain (scope 3) GHG emissions by 30%
  • By 2025, 100% of purchased electricity will come from renewable sources.

SDG Focus Area(s):

Summary

Engage with suppliers to drive positive sustainable change. By 2025, at least 90% of strategic suppliers with the highest environmental impact to set their own GHG emission and water use reduction targets.

Objectives

Engage with suppliers to drive positive sustainable change

Metrics & Targets

  • By 2018, started collecting GHG emissions and water use data from at least 90% of strategic suppliers with the highest environmental impact.
  • By 2020, engage with those suppliers and request them to identify GHG emission and water use reduction opportunities.
  • By 2025, at least 90% of strategic suppliers with the highest environmental impact to set their own GHG emission and water use reduction targets.

SDG Focus Area(s):

Summary

Promote employee diversity and inclusion within the enterprise through Global Diversity and Inclusion Strategies

Objectives

Promote employee diversity and inclusion within the enterprise through global diversity and inclusion strategies

Metrics & Targets

  • Committed to increasing the percentage of women on the senior management team and in management roles, which was 43% in 2019.
  • Committed to increasing the percentage of members of underrepresented ethnic groups on the board, which was 25% in 2019.
  • Committed to making available business resource groups focused on building cultural awareness, sharing business insights and supporting talent, inclusion and corporate reputation goals.
  • Committed to making available educational programs and tools to further the career advancement and managerial skills of employees.

SDG Focus Area(s):

Summary

Advance a culture of health by supporting the health and wellbeing of our employees and their families through integrated policies, programs and environmental cues

Objectives

Advance a culture of health by supporting the health and wellbeing of our employees and their families through integrated policies, programs and environmental cues

Metrics & Targets

  • Building from a 70% benchmark achieved company-wide in 2018, continue to improve employees’ perception that: “Senior leadership is interested in the wellbeing of employees”
  • By 2022 in the US, achieve 700 points on the HealthNEXT Employer Health Opportunity Assessment
  • By the end of 2020, achieve 100% comprehensive global tobacco-free work sites. (This goal was achieved in the US in 2018)
  • Advance appropriate adult vaccination coverage. As an example, achieve 70% of US-based employees vaccinated against the flu by year-end, 2020.

SDG Focus Area(s):

Summary

Identify and meet the healthcare needs of patients through continuous innovation and scientific excellence

Objectives

Identify and meet the healthcare needs of patients through continuous innovation and scientific excellence

Metrics & Targets

  • Percentage of products and pipeline that address the top 20 global burdens of disease
  • Total R&D expenses

SDG Focus Area(s):

Summary

Strive to ensure all suppliers operate in a matter consistent with the Business Partner Code of Conduct as well as the PSCI Pharmaceutical Industry Principles and the Ten Principles of the United Nations Global Compact

Objectives

Strive to ensure all suppliers operate in a matter consistent with the Business Partner Code of Conduct, which is based on the company’s Code of Conduct, as well as the Pharmaceutical Supply Chain Initiative's (PSCI) Pharmaceutical Industry Principles and the Ten Principles of the United Nations Global Compact

Metrics & Targets

  • Committed to conducting external manufacturing EHS assessments; Conducted 91 in 2019.
  • Since implementing the company’s Labor and Human Rights program in 2015, have conducted 234 onsite audits in countries identified as high risk for potential human rights violations.

SDG Focus Area(s):

Summary

Conduct clinical trials, including trials in Low-Income and Middle-Income countries, in accordance with the global standards of Good Clinical Practices and applicable local regulatory requirements

Objectives

Conduct clinical trials, including trials in Low-Income and Middle-Income countries, in accordance with the global standards of Good Clinical Practices, applicable local regulatory requirements and following the ethical principles that have their origin in the Declaration of Helsinki.

Metrics & Targets

In 2019,  0 GCP/PV inspections by regulatory agencies of the company or clinical trial investigators led to significant fines, penalties, warning letters or product seizures

SDG Focus Area(s):

Summary

Ensure product quality and safety

Objectives

Ensure product quality and safety

Metrics & Targets

Committed to minimizing the number of sold units recalled during a given year; In 2019, the company’s recall rate globally was 0.01%.

SDG Focus Area(s):

Summary

Promote the reuse and recycling of water at our facilities around the globe with the goal, by 2025, to maintain global water use at or below 2015 levels.

Objectives

Promote the reuse and recycling of water at our facilities around the globe

Metrics & Targets

  • By 2020, develop water conservation plans for sites in “high water risk” locations.
  • By 2025, maintain global water use at or below 2015 levels.

SDG Focus Area(s):

Summary

Improve resource efficiency and decrease waste disposal needs with the goals, by 2025, of 20% or less of global operational waste sent to landfills and incinerators, and at least 50% of sites to send zero waste to landfill.

Objectives

Improve resource efficiency and decrease waste disposal needs

Metrics & Targets

By 2025, 20% or less of global operational waste sent to landfills and incinerators.
By 2025, at least 50% of sites to send zero waste to landfill.

SDG Focus Area(s):

Summary

Through commitment to gender equality, Merck strives to continue to be included in the Bloomberg Gender Equality Index

Objectives

Promote gender equality through participation in the Bloomberg Gender Index

Metrics & Targets

  • Bloomberg Gender Index score, a measurement of companies’ promotion of gender equality based on female talent and leadership pipeline, equal pay and gender pay parity, inclusive culture, sexual harassment policies, and support for pro-women brands.

SDG Focus Area(s):

Summary

Promote supplier diversity through Global Economic Inclusion and Supplier Diversity Strategies

Objectives

Promote supplier diversity through global economic inclusion and supplier diversity strategies

Metrics & Targets

Committed to increasing spend on diverse suppliers (minority-owned, women-owned, veteran-owned, LGBT-owned and disability-owned business enterprises) and small-business suppliers, which $2.4 billion and $979 million, respectively, in 2019.

SDG Focus Area(s):

Summary

Contribute scientific and business expertise, as well as financial resources, to reduce preventable maternal deaths globally through Merck for Mothers

Objectives

Contribute scientific and business expertise, as well as financial resources, to reduce preventable maternal deaths globally through Merck for Mothers

Metrics & Targets

Working alongside more than 180 collaborators, Merck for Mothers has reached more than 10.9 million women in 48 countries around the world since 2011, furthering the global effort to save women’s lives, strengthen health systems and meet the UN SDGs. Efforts have supported 52 million people in having improved access to facilities where the quality of care has been improved.

SDG Focus Area(s):

Summary

Collaborate with diverse partners to expand R and D capacity and enable access to compound libraries to address unmet needs

Objectives

Collaborate with diverse partners to expand research and development capacity and enable access to compound libraries to address unmet needs

Metrics & Targets

  • Number of established significant external licenses and collaborations

SDG Focus Area(s):

Summary

Expand access to our products through dedicated, market-based affordability solutions that allow flexibility to reach at-need populations and patients

Objectives

Expand access to our products through dedicated, market-based affordability solutions that allow flexibility to reach at-need populations and patients — including those in low-income and middle-income countries — taking into consideration public health need, economic conditions and health care infrastructure.

Metrics & Targets

• Committed to initiating dedicated affordability solutions; in 2019, dedicated affordability solutions where initiated in 40 countries.

SDG Focus Area(s):

Summary

When market-based solutions are inadequate or unavailable, pursue programs to provide direct access to our medicines and vaccines

Objectives

When market-based solutions are inadequate or unavailable, pursue programs to provide direct access to our medicines and vaccines, including product donations and patient assistance programs.

Metrics & Targets

People reached globally through product donation and patient assistance programs and partnerships; in 2019, 404,000,000 people were reached through the company’s product donations and patient assistance programs and partnerships.

SDG Focus Area(s):

Summary

In partnership with local communities and other stakeholders, support capacity building for health systems and care delivery where our support can make a meaningful difference.

Objectives

In partnership with local communities and other stakeholders, support capacity building for health systems and care delivery where our support can make a meaningful difference. Address underlying barriers to access, including social determinants of health, that lead to health inequities.

Metrics & Targets

• Annual investment in partnerships, programs and impact investments that support health care capacity-building and address underlying barriers to access to health; In 2019, the annual investment was $63 Million.

• People reached through investment in partnerships, programs and impact investment that support health care capacity-building and address underlying barriers to access to health; 2019, the number of people reached was 422 Million.

SDG Focus Area(s):

Sign up your company

Recognizing it will take alignment of all our organizations to scale impact globally, we invite you to join the movement as a Steward of Inclusive Capitalism. Together, the collective action of Council members will contribute to a fairer, more inclusive and sustainable future for all people and our planet.